Themis Medicare Limited (NSE:THEMISMED)

Market Cap	9.23B
Revenue (ttm)	3.80B
Net Income (ttm)	-90.71M
Shares Out	n/a
EPS (ttm)	-0.98
PE Ratio	n/a
Forward PE	n/a
Dividend	0.50 (0.50%)
Ex-Dividend Date	Sep 4, 2025

Volume	41,449
Average Volume	384,813
Open	100.53
Previous Close	101.11
Day's Range	99.04 - 101.69
52-Week Range	99.04 - 317.00
Beta	-0.22
RSI	32.99
Earnings Date	Aug 14, 2025

About Themis Medicare

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolyti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 1,702
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: THEMISMED

Financial Performance

In 2024, Themis Medicare's revenue was 4.06 billion, an increase of 6.22% compared to the previous year's 3.82 billion. Earnings were 298.33 million, a decrease of -31.46%.